Miza Pharmaceuticals USA
This article was originally published in The Tan Sheet
Executive Summary
Purchase of NutraMax's Optopics Laboratories ophthalmics division gives the Burlington, Mass.-based contract manufacturing and packaging firm an OTC product base that includes branded and private label eye drops, artificial tears, contact lens solution and cleansers, and industrial eye wash, along with eight Rx products. The deal closed Dec. 31 for an undisclosed sum; Optopics' FY 1998 sales totaled approximately $12 mil. Under the terms of the transaction, Miza acquired the division's 34,000 sq. ft. manufacturing and office facility in Fairton, N.J. The company anticipates no reductions in Optopics' 86-employee work force
You may also be interested in...
P&G Merger Talks Bring Pharmaceutical-As-Consumer-Brand Idea To Fore
Procter & Gamble's aborted merger discussions with Warner-Lambert and American Home Products may herald the next phase in the evolution of consumer-focused pharmaceutical marketing.
P&G Merger Talks Bring Pharmaceutical-As-Consumer-Brand Idea To Fore
Procter & Gamble's aborted merger discussions with Warner-Lambert and American Home Products may herald the next phase in the evolution of consumer-focused pharmaceutical marketing.
P&G Merger Talks Bring Pharmaceutical-As-Consumer-Brand Idea To Fore
Procter & Gamble's aborted merger discussions with Warner-Lambert and American Home Products may herald the next phase in the evolution of consumer-focused pharmaceutical marketing.